Laboratory Corporation of Ameri (LH) Financials
LH Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 16.7 billion | 8.8 billion |
| 2023-09-30 | 16.9 billion | 9.0 billion |
| 2023-06-30 | 17.7 billion | 8.9 billion |
| 2023-03-31 | 20.2 billion | 9.8 billion |
LH Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 412.4 million | 27.0 million |
| 2023-09-30 | 170.6 million | 34.4 million |
| 2023-06-30 | 248.8 million | 34.4 million |
| 2023-03-31 | 27.3 million | 40.6 million |
LH Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | -167.1 million |
| 2023-09-30 | 183.6 million |
| 2023-06-30 | 155.0 million |
| 2023-03-31 | 213.3 million |
LH Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 536.8 million | - | 899.7 million |
| 2023-09-30 | 727.9 million | 4.5 billion | 911.3 million |
| 2023-06-30 | 1.9 billion | 5.1 billion | 866.5 million |
| 2023-03-31 | 393.9 million | 5.1 billion | 937.6 million |
LH Shares Outstanding
LH Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 167.2 million | - | 532.9 million | - |
| 2023-09-30 | 104.9 million | - | 525.5 million | - |
| 2023-06-30 | 102.6 million | - | 505.8 million | - |
| 2023-03-31 | 93.9 million | - | 553.6 million | - |
LH Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 3.0 billion | 2.3 billion |
| 2023-09-30 | 3.1 billion | 2.2 billion |
| 2023-06-30 | 3.0 billion | 2.2 billion |
| 2023-03-31 | 3.8 billion | 2.8 billion |
LH
Price: $198.35
Dividend Yield: 0.01%
Forward Dividend Yield: 1.45%
Payout Ratio: 29.66%
Dividend Per Share: 2.88 USD
Earnings Per Share: 4.33 USD
P/E Ratio: 22.78
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 347600
Ebitda: 501.8 millionMarket Capitalization: 17.5 billion
Average Dividend Frequency: 3
Years Paying Dividends: 3